Menu
← Oncology Approval Tracker
FDA DECISION ·
Pemetrexed injection
pemetrexed · Actavis
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Single-agent maintenance of locally advanced or metastatic nonsquamous non-small cell lung cancer without progression after four first-line platinum cycles, or treatment of recurrent metastatic nonsquamous disease after chemotherapy.
LAMPGEN ANALYSIS
Why it matters
Added a separately approved pemetrexed presentation for selected nonsquamous lung cancer uses.
What research teams should watch
Use product-specific dilution instructions and verify that the intended regimen matches this label.
PRIMARY RECORDS